Disclaimer

Affymax, Inc., (“Affymax”) maintains the Affymax Web site as a service to the Internet community. The Affymax Web site has been designed to provide general information about Affymax and its products. These pages are not intended to provide investment or medical advice, nor do they provide instruction on the appropriate use of products produced or supplied under development by Affymax, its affiliates, related companies, or its licensors or joint venture partners. Users of this Web site should be aware that products under development described herein have not been found safe or effective by any regulatory agency and are not approved for any use outside of clinical trials. Access and use of the Affymax Web site is subject to the terms and conditions set forth herein and all applicable laws, statutes, and/or regulations. Affymax may revise these terms and conditions from time to time without further notice by updating this posting.

Affymax makes no warranties or representations as to the accuracy of information presented on the Affymax Web site. In addition, any information presented on the Web site as of a particular date may only be accurate as of such date. Affymax disclaims any responsibility to update such information. Affymax shall not be held responsible for any action taken that is based on the information presented on the Affymax Web site, and all users of the Affymax Web site agree that all access and use of the Affymax Web site, and any and all content presented on the Affymax Web site, is at the user’s own risk. Neither Affymax nor any party involved in creating, producing or delivering this site shall be liable for any direct, incidental, consequential, indirect, or punitive damages arising out of user’s access, use, or inability to use the Affymax Web site, or any errors or omissions in the content of the Affymax Web site. Any communication or material you transmit to Affymax via the Affymax Web site or Internet electronic mail is transmitted by you on a nonconfidential basis. Affymax makes no promise, express or implied, not to use such communication or material for any purpose whatsoever, including reproduction, publication, broadcast and posting.

It is the policy of Affymax to enforce its intellectual property rights to the fullest extent permitted under law. All product names, regardless of whether or not they appear in large print or with a trademark symbol, are trademarks of Affymax, its affiliates, related companies, or its licensors or joint venture partners, unless otherwise noted. The entire content of the Affymax Web site, including any images or text, is copyrighted and may not be distributed, downloaded, modified, reused, reposted, or otherwise used except as provided herein without the express written permission of Affymax Inc. The use or misuse of these trademarks, copyrights, or other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, communications regulations and statutes, and other laws, statutes and/or regulations.

Note on Forward-looking Information: This Web site contains forward-looking statements, including statements regarding financial condition, the success of Affymax's collaboration with Takeda, timing, design and results of Affymax's clinical trials and drug development program and the timing and likelihood of the commercialization of Hematide. Affymax's actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties, including risks relating to the continued safety and efficacy of Hematide in clinical development, the timing of patient accrual in ongoing and planned clinical studies, regulatory requirements and approvals, research and development efforts, industry and competitive environment, intellectual property rights and disputes and other matters that are described under the caption "Risk Factors" in Affymax's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, as the posting. Affymax undertakes no obligation to update these forward-looking statements.